Clinical effectiveness of Chinese patent medicines for functional constipation: insights from a systematic review and Bayesian network-meta-analysis

Abstract

Introduction In recent years, guidelines and consensus statements have recommended Chinese patent medicines (CPMs) for the treatment of functional constipation (FC). The latest Chinese Health Care Directory also lists CPMs for FC; however, the supporting evidence remains insufficient. In this study, we aimed to evaluate the effectiveness and safety of CPMs in the treatment of FC using a network-meta-analysis (NMA). Methods We searched for eligible randomized controlled trials (RCTs) published in the databases of PubMed, Cochrane Library, Embase, SinoMed, China National Knowledge Infrastructure, Wanfang, and Chinese Scientific Journals Database. Bayesian NMA and pairwise comparisons were performed to determine the frequency of spontaneous bowel movements, clinical effects, recurrence rate, dyschezia score, and defecation time score. Results A total of 61 studies were included. The methodological quality of the included studies was relatively poor, and the reliability of the synthetic outcomes was low. Our findings indicate that in older individuals, according to the self-established clinical efficacy criteria, Liuwei Anxiao combined with prokinetics demonstrated superior clinical effectiveness compared to prokinetic monotherapy (risk ratio [RR]: 1.46, 95% confidence interval [CI]: 1.17, 1.96), with lower scores for defecation times (mean difference: −0.30, 95% CI: −0.60, −0.02). Dalitong granules combined with prokinetics showed better clinical efficacy than prokinetic monotherapy (RR: 1.59, 95% CI: 1.03, 2.53). In older participants, based on published clinical efficacy criteria, Shouhui Tongbian capsule combined with an osmotic laxative exhibited superior clinical effectiveness compared to osmotic laxative monotherapy (RR: 1.21, 95% CI: 1.00, 1.48). Reported adverse events included stomachache, diarrhea, and nausea. Conclusions Several positive outcomes were observed, including better clinical effects across different criteria and lower defecation frequency scores. However, the quality of the included studies and the conclusions on CPM coverage areas were limited. Future research should include more high-quality studies directly comparing the effects of different CPMs.

Keywords

Chinese patent medicine / functional constipation / systematic review / network meta-analysis / traditional Chinese medicine

References

[1] Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011; 25(1):3-18.

[2] Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011; 106(9):1582-1591;quiz1581, 1592.

[3] Casias A, Newton L.Functional constipation: a case report. J Pediatr Health Care. 2021; 35(1):99-103.

[4] Long Y, Huang Z, Deng Y, et al. Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria. Neurogastroenterol Motil. 2017; 29(1):1-9.

[5] Barberio B, Judge C, Savarino EV, Ford AC. Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021; 6(8):638-648.

[6] Liu B, Liu Y. Comparison analysis between domestic and foreign guidelines on constipation diagnosis and treatment. J Army Med Univ. 2019; 41(19):1846-1851.

[7] Chinese Medical Association. Guideline for primary care of chronic constipation (2019). Chin J Gen Pract. 2020; 19(12):1100-1107.

[8] Ma K, Pang B, Zhang MY, Li J, Lu Y. Acupuncture and moxibustion for functional constipation: a systematic review and meta-analysis. Henan Tradit Chin Med. 2019; 39(4):616-624.

[9] Fang YP, Huang YT, Chen D, et al. Systematic review and meta analysis on the effectiveness and safety of Tuina in treatment of functional constipation. Chin Acupunct Moxibust. 2021; 41(6):691-698.

[10] Zhang XX. Analysis on development trend of Chinese patent medicine industry in new period. Mod Chin Med. 2020; 22(9):1415-1418,1457.

[11] Cui WW, Guan ZA. Research advances in traditional Chinese medicine for the diagnosis and treatment of chronic constipation. Mod J Integr Tradit Chin West Med. 2021; 30(36):4094-4099.

[12] Jiang L, Xia W, Zhu MJ, et al. Liuwei Anxiao capsule in treating functional constipation: a meta-analysis of randomized controlled trials. J Liaoning Univ Tradit Chin Med. 2012; 14(12):138-141.

[13] Zhang CX, Liao WM. Efficacy of Maziren Wan for constipation: a meta-analysis of randomized controlled trials. World Latest Med Inf. 2019; 19(99):22-24.

[14] Tian JH, Li L, Zhao Y, Ma JC, Li JL, Ge L. The descriptive analysis of the network meta-analysis. Chin J Drug Eval. 2014; 31(3):129-133.

[15] Higgins JPT, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, United Kingdom: John Wiley & Sons; 2019.

[16] Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015; 162(11):777-784.

[17] Li JX, Chen Y, Ke X. Consensus on the diagnosis and treatment of functional constipation with integrated traditional Chinese and Western medicine (2017). Chin J Integr Tradit West Med Dig. 2018; 26(1):18-26.

[18] Li Y, Wang B, Yu PL, et al. Expert consensus on the diagnosis and treatment of functional constipation in older adults with integrated traditional Chinese and Western medicine. Chin J Geriatr. 2019; 38(12):1322-1328.

[19] Shen H, Zhang L, Ye B. Expert consensus on the diagnosis and treatment of constipation. Beijing J Trad Chin Med. 2017; 36(9):771-776.

[20] Hu ML, Zheng G, Lin H, Yang M, Zhang YD, Han JM. Network meta-analysis on the effect of desensitizing toothpastes on dentine hypersensitivity. J Dent. 2019; 88:103170.

[21] van Valkenhoef G, Lu G, de Brock B, Hillege H, Ades AE, Welton NJ.Automating network meta-analysis. Res Synth Methods. 2012; 3(4):285-299.

[22] Sterne JAC, Sutton AJ, Ioannidis JPA, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.

[23] Lu XR, Xu JK, Tao MH. Clinical observation on treatment with Bianmitong. Guangming J Chin Med. 2012; 27(3):464-465.

[24] Guan L, Zhao H, Tang XY. Tongyouwan in the treatment of functional constipation: an analysis of 57 cases. Chin J Integr Trad West Med Dig. 2013; 21(6):332-333.

[25] Li YW, Li XW. Clinical trial of Biannaitong tea for constipation. J Hubei Coll TCM. 2005; 7(4):50-51.

[26] Ji MZ, Zhang YJ. Effectiveness comparison of Maren Wan and mosapride in treatment of functional constipation. Chin Gen Pract. 2005; 8(20):1711-1712.

[27] Wang J. Clinical observation of Jiaolong capsules combined with Bifidobacterium in treatment for functional constipation. Drugs Clin. 2017; 32(8):1474-1477.

[28] Zhang L, Li N, Di ZL, Liu TL. Liuwei Anxiao capsule for functional constipation in stroke patients: a clinical study of 160 cases. J Pract Med Tech. 2006; 13(13):2251-2252.

[29] Yuan LH, Zhang SN. Study on the effectiveness of Liuwei Anxiao capsule combined with mosapride in the treatment of chronic functional constipation. China Mod Dr. 2017; 55(7):40-42.

[30] Jiang JH, Dong YX. Efficacy of Liuwei anxiao capsule combined with prucalopride on functional constipation in older patients. Int J Geriatr. 2021; 42(1):49-53.

[31] Wei J, Cui Y. Clinical observation of Maziren capsule combined with live combined Bifidobacterium and Lactobacillus tablets in the treatment of functional constipation of hot product. Drugs Clinic. 2018; 33(2):363-367.

[32] Chen JH, Li ZH. Clinical observation on Maren Wan combined with lactulose for functional constipation in 64 older patients. J Guangxi Univ Chin Medi. 2016; 19(2):26-28.

[33] Lin SS, Zhang D, Bo LB, Liu ZX. Clinical efficacy of the Liuwei Anxiao capsule plus mosapride on chronic functional constipation. Clin J Chin Med. 2018; 10(25):100-101.

[34] Huo H, Li Y, Zhang Yi, et al. Liuwei Anxiao capsule and mosapride capsule in treatment of chronic functional constipation. Chin Arch Trad Chin Med. 2016; 34(3):734-736.

[35] Nian XL. Efficacy of Liuwei Anxiao capsule and lactulose oral solution in the treatment of senile functional constipation. China Mod Med. 2014; 21(7):65-66.

[36] Chen J, Huang ZJ, Zhang Y, Duan YQ. Clinical observation on Liuwei Anxiao capsule for constipation in 43 older patients. Med J Natl Defend Forces Southwest China. 2009; 19(6):615-616.

[37] Hu C. Clinical observation on the combination of Liuwei Anxiao and lactulose for functional constipation in older patients. World Latest Med Inf. 2016; 16(65):122-123.

[38] Liu S, Jiang JG. Effects of Shouhui Tongbian capsule on serum MTL and SP levels in older patients with functional constipation. Mod Med Health Res. 2020; 4(9):122-124.

[39] Zhou AY, Yuan B, Liu SJ, Wang YF, Li SS. Effect of Shouhui Tongbian capsule combined with mosapride on serum SP, MTL, NO levels and quality of life in patients with functional constipation. Prog Mod Biomed. 2021; 21(18):3448-3451.

[40] Gou LL, Zhang HZ, Xiao BY. Clinical observation on Maren Runchang pill for functional constipation in 23 older patients. Theory Pract Chin Med. 2006; 16(10):1213-1214.

[41] Ma JJ, Bing D. Clinical observation of Qihuang Tongmi soft capsules in the treatment of functional constipation. Drugs Clin. 2015; 30(1):74-78.

[42] Cheng CW, Bian ZX, Zhu LX, Wu JCY, Sung JJY. Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation. Am J Gastroenterol. 2011; 106(1):120-129.

[43] Yuan B, Zhang JP, Wang SC, Shi XW, Li SS. Effect of Shouhui Tongbian capsule combined with lactulose oral liquid on anxiety, depression and serum gastrointestinal hormones in patients with senile functional constipation. Prog Mod Biomed. 2021; 21(17):3281-3284.

[44] Qiao XY, Ji HZ. Comparison of cost-effectiveness among four drugs for the treatment of functional constipation in older patients. Herald Med. 2008; 27(5):604-605.

[45] Wei JA. Clinical observation on Jiangzhi Tongbian capsule in the treatment of 60 cases of functional constipation. Chin Community Doc. 2012; 28(35):13.

[46] Chen H, Fan KH, Yu BT, Jin WH, Wang XH, Zhao T. Clinical controlled observation of macrogol 4000 and edestan for senile chronic functional constipation. Med J West China. 2011; 23(11):2168-2169.

[47] Li TH, Ou Yang JD. Clinical observation on the combination of polyethylene glycol-electrolyte powder and Maren pill for functional constipation in older patients. Chin J Clinical Rational Drug Use. 2016; 9(7):95-96.

[48] Cao XR. Clinical observation on Liuwei Anxiao capsule in the treatment of 47 cases of functional constipation. China Pharm. 2012; 21(6):73.

[49] Zhang X, Ou Yang JD. Clinical observation on Liuwei Anxiao capsule in the treatment of 30 cases of adolescent functional constipation. Guangming J Chin Med. 2016; 31(9):1246-1247.

[50] Shi ZD. Clinical observation of Qirong Runchang oral liquid combined with lactulose in the treatment of senile functional constipation. China Pharm. 2013; 24(23):2184-2186.

[51] Zheng JY, Nong H. Efficacy of Luhui Zhenzhu capsule combined with live Bacillus coagulans tablets in the treatment of functional constipation in older adults. Intern Med. 2017; 12(2):243-244.

[52] Liu W. Efficacy of mosapride plus Danshitong for functional constipation in older adults. Chin J Mod Drug Appl. 2015; 9(21):130-131.

[53] Ma J, Cao XY. Clinical observation of Simotang oral liquid combined with bisacodyl in the treatment of elderly functional constipation. Drugs Clinic. 2018; 33(10):2608-2610.

[54] Huang CQ, Li ZH, Guan LN. Efficacy of simotang oral solution combined with lactulose for senile functional constipation. In: Proceedings of the 2017 Pharmaceutical Conference of Guangdong Province. Guangzhou, China; 2017:1-4.

[55] Wang YZ. Clinical efficacy of Liuwei Anxiao capsule for functional constipation. Med Inform. 2014; 27(7):171-172.

[56] Yao XX, Wang Y, Zhang XS, Li T. Clinical observation on Liuwei Anxiao capsule combined with polyethylene glycol 4000 powder in the treatment of older functional constipation. Chin Manip Rehabil Med. 2011; 2(18):88.

[57] Jia JC, Li YN. Effect of Liuwei Anxiao capsule in the treatment of functional constipation. Chin J Pract Chin Mod Med. 2003; 16(10):1385-1386.

[58] Gu Y, Yu Y, Zhang ZY, Yu XF, Yao JF. The effect of Congrong purgative oral solution combined with lactulose on the treatment of elderly constipation patients. Geriatr Health Care. 2015; 21(2):109-111.

[59] Ju HY. Clinical effect of Buzhong Yiqi decoction combined with cisapride on functional constipation in older adults. Chin Med Mod Dist Educ China. 2013; 11(23):74.

[60] Ren Q, Zhang H, Wang XF, Chen Y, Huang Y. Observation of therapeutic effect of Dalitong granules combined with mosapride citrate in treatment of chronic functional constipation. China Pharm. 2010; 19(6):62-63.

[61] Yan X, Guo MY. Low-dose Liuwei Anxiao combined with polyethylene glycol 4000 for functional constipation in the elderly: a report of 25 cases. Chin J Integr Trad Wes Med Dig. 2006; 14(1):56-57.

[62] Guan HP, Zu ZY. Efficacy of itopride combined with Maren Runchang pill in elderly functional constipation: a clinical observation of 79 cases. Aerosp Med. 2009; 19(8):94.

[63] Zhang J. A effect analysis of combining liuweianxiao capsule with mospride citrate tablets for functional constipation in old patients. J Math Med. 2012; 25(3):330-331.

[64] Qu QF, Bai XR. Efficacy of Liuwei Anxiao capsule combined with mosapride citrate tablets in chronic functional constipation. Inn Mong Med J. 2008; 40(9):1048-1049.

[65] Li SJ, Hu XD, Luo M. Summary of 32 cases of functional constipation in the elderly treated with hemp seed capsule combined with cisapride. Hunan J Tradit Chin Med. 2011; 27(4):19-20.

[66] Sun XJ. Observation on curative effect of Maren soft capsules in treatment of senile constipation. Chin Tradit Herb Drugs. 2018; 49(11):2629-2631.

[67] Peng J, Liu Z. Liuwei Anxiao capsules for functional constipation. In: Proceedings of the 2011 Academic Annual Conference of Jiangxi Provincial Association of Chinese Medicine. Nanchang, China; 2011.

[68] Huang JL, Rong HY, Zhu YL, Zhang M. The therapeutic effects of medilac-S with Liuwei-anxiao on chronic functional constipation. Guide China Med. 2014; 12(13):14-15.

[69] Su HX. Clinical observation effect of mosapride and Simo decoction on chronic functional constipation. J Huaihai Med. 2004; 22(3):178-179.

[70] Wang P. Efficacy observation of lactulose oral solution in the treatment of functional constipation in 30 aged patients. Jilin Med J. 2014; 25(18):3947-3948.

[71] Shi JF, Ye Z. Observation of the efficacy of cisapyride in the treatment of functional constipation. Strait Pharm J. 2003; 15(6):71-72.

[72] Xiao N, Zhang S, Yang XP, Gou XQ, Guo J. Tan K. Efficacy of Liuwei Nengxiao capsules combined with mosapride citrate tablets in the treatment of functional constipation in elderly patients: an observational study. Chin J Inf Tradit Chin Med. 2010; 2(16):184-186.

[73] Jiang H, Wang XY, Li JM, Zhang HJ, Zhang X, Lu SJ. Clinical observation of Qihuang Tongmi soft capsule in phase II in the treatment of functional constipation. Chin J Clin Pharmacol. 2011; 27(2):100-103.

[74] Xu ZX, Lu J, Wu SJ, Cai L. Clinical study of Qirong Runchang oral liquid combined with glucomannan capsule in the treatment of functional constipation in the elderly. J Pract Tradit Chin Med. 2014; 30(9):854.

[75] Lin M, Liu Y. Liuwei Anxiao capsule treats senile functional constipation 60 cases. J Zhejiang Chin Med Univ. 2009; 33(2):232-233.

[76] Jiang XY. Summary of 43 cases of chronic transit constipation treated by Liuwei Anqi capsules. Hunan J Tradit Chin Med. 2010; 26(1):12-13.

[77] Yang MW, Yang Y. Mosapride combined with Danshitong in the treatment of elderly functional constipation: an analysis of 87 cases. Chin J Clin Gastroenterol. 2015; 27(1):46-47.

[78] Liu SJ, Xie XF. Clinical observation on treating functional constipation with Sixiao Wan. Clin J Chin Med. 2015; 7(22):110-112.

[79] Zhou YY. Liuwei Anxiao in the treatment of chronic transit constipation: a summary of 38 cases. Hunan J Tradit Chin Med. 2009; 25(2):22-23.

[80] Huang B. Clinical efficacy of Houpo Paiqi Heji combined with mosapride in the treatment of functional constipation. J Front Med. 2015; 5(10);211-212.

[81] Zou Y. Clinical Study on Shouhui Tongbian Capsule in the Treatment of Functional Constipation Due to Qi-Yin Deficiency Based on the Theory of “Treating Constipation with Tonification” [master’s thesis]. Shenyang, China: Liaoning University of Traditional Chinese Medicine; 2024.

[82] Wu YF. Effect of Niuhuang Shangqing capsule combined with Bifico on chronic functional constipation in middle-aged and elderly patients and its influence on gastrointestinal hormone level. Zhejiang J Tradit Chin Med. 2025; 60(8):675-677.

[83] Tang XD, Lu F, Yang Q, et al. A multicenter, randomized, placebo-controlled clinical study evaluating the clinical efficacy of Simo decoction oral liquid in the treatment of functional constipation (qi stagnation constipation). Chin Arch Tradit Chin Med. 2025. https://link.cnki.net/urlid/21.1546.r.20250609.1443.004. Accessed October 15, 2025.

[84] Wang TY, Chen ZX, Wang YB, et al. The curative effect of Shouhui Tongbian capsules in the treatment of chronic constipation may be better than conventional treatment in Western medicine: a systematic review based on randomized controlled trials. Chin Gen Pract. 2021; 24(23):2972-2977.

[85] Dai ZQ. EVIDEM Framework (Evidence and Value) Adapted for Clinical Comprehensive Evaluation of Chinese Patent Medicines: Development and Case Study [dissertation]. Beijing, China: China Academy of Chinese Medical Sciences; 2023.

[86] Lyu Z, Fan Y, Bai Y, Liu T, Zhong LL, Liang HF. Outcome of the efficacy of Chinese herbal medicine for functional constipation: a systematic review and meta-analysis. World J Clin Cases. 2022; 10(15):4856-4877.

[87] Lin J. A critical analysis of problems in meta-analyses of traditional Chinese medicine. J Clin Med. 2017; 4(53):10480-10481.

[88] Wu T, Shang H, Bian Z, et al. Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine. J Evid Based Med. 2010; 3(1):11-17.

[89] Xu C, Furuya-Kanamori L, Zorzela L, Lin L, Vohra S. A proposed framework to guide evidence synthesis practice for meta-analysis with zero-events studies. J Clin Epidemiol. 2021; 135:70-78.

[90] Hong H, Wang C, Rosner GL. Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods. Clin Trials. 2021; 18(1):3-16.

[91] Tan F, Guan HQ, Mu YF, Liu C, Fan QL. Advantages and application of Chinese patent medicine in the treatment of chronic constipation. World Chin Med. 2021; 16(24):3637-3642.

[92] National Medical Production Administration. NMPA announcement on the cancellation of registration certificates for phenolphthalein tablets and phenolphthalein buccal tablets. https://english.nmpa.gov.cn/2021-01/14/c_596715.htm. Accessed May 20th, 2025.

[93] Russo M, Strisciuglio C, Scarpato E, Bruzzese D, Casertano M, Staiano A. Functional chronic constipation: Rome III criteria versus Rome IV criteria. J Neurogastroenterol Motil. 2019; 25(1):123-128.

[94] Zhang YY, Shen C, Zhang Y, Liu JP. Misunderstandings in using “total effective rate” as an index for evaluating the therapeutic effect of traditional Chinese medicine. Chin J Drug Eval. 2020; 37(5):337-340.

[95] Zhong LD. Current situation, challenge and future development of post marketing evaluation on proprietary Chinese medicines. World Chin Med. 2017; 12(6):1218-1220,1225.

[96] National Administration of Traditional Chinese Medicine. The National Pharmacopoeia Commission plans to publicly disclose the formulations and manufacturing processes of 256 proprietary Chinese medicines. http://www.natcm.gov.cn/xinxifabu/shizhengyaowen/2019-10-17/11556.html. Accessed May 20, 2025.